The global healthcare landscape is currently facing a formidable challenge in the form of Clostridioides difficile (C. diff), a bacterium that has become a leading cause of hospital-acquired infections. As of 2026, the Difficile-Associated Diarrhea (DAD) Treatment Market is undergoing a seismic shift, moving away from a purely "kill the pathogen" antibiotic approach toward a "restore ... https://www.databridgemarketresearch.com/